Login

Balance sheets

In millions of USD, except per-share amounts
Q3 FY2024
As of Jun 30, 2024
Q2 FY2024
As of Mar 31, 2024
Q1 FY2024
As of Dec 31, 2023
Q4 FY2023
As of Sep 30, 2023
Q3 FY2023
As of Jun 30, 2023
Q2 FY2023
As of Mar 31, 2023
Q1 FY2023
As of Dec 31, 2022
Q4 FY2022
As of Sep 30, 2022
Q3 FY2022
As of Jun 30, 2022
Q2 FY2022
As of Mar 31, 2022
Q1 FY2022
As of Dec 31, 2021
Q4 FY2021
As of Sep 30, 2021
Q3 FY2021
As of Jun 30, 2021
Assets
Cash
Prepaid expenses
Total current assets
Cash held in Trust Account
Total Assets
Liabilities, Common Stock Subject to Possible Redemption and Stockholders' Deficit
Current liabilities:
Accounts payable and accrued expenses
Taxes payable
Accrued Liabilities, Current
Accounts payable
Franchise tax payable
Income tax payable
Subscription agreements liability, net
Promissory Notes-Related Party
Excise tax payable
Accrued offering costs
Total current liabilities
Common stock subject to possible redemption, 1,417,687 and 2,363,349 shares at redemption value of approximately $11.31and $10.71 per share at June 30, 2024 and September 30, 2023, respectively
Stockholders' Deficit:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Common stock, $0.0001 par value; 100,000,000 shares authorized, 5,709,500 shares issued and outstanding (excluding 1,417,687 and 2,363,349 shares subject to possible redemption) at June 30, 2024 and September 30, 2023, respectively
Additional paid-in capital
Accumulated deficit
Total Stockholders' Deficit
Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders' Deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support